IV.5 High grade endometrial cancers associated with tamoxifen use

European Journal of Cancer

Volumn 34, Issue SUPPL. 4, 1998, Pages

  Van Hooff, I ^a  

^a Brussels Heart Centre   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

BREAST CANCER; CLINICAL ARTICLE; CONFERENCE PAPER; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; FEMALE; HUMAN; HYSTERECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL;

EID: 0031662391     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00111-7     Document Type: Conference Paper

References (2)

1. Cohen CJ, Rahaman J. Endometrial cancer: management of high risk and recurrence including the tamoxifen controversy. Cancer 1995, 76(10) Suppl., 2044-2052.
2. Magriples U, Naftolin F, Schwartz PE, Carcangiu, ML. High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients. J Clin Oncol 11, 485-490.